← Scroll for more →
Candel Therapeutics, Inc. (CADL)
Biological Products, (No Diagnostic Substances)
Latest Price
$8.33
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.72
P/B Ratio
4.84
Institutional Ownership
66.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 10.99M | $113.0M | 14.44% | +3.5K | 2026-06-30 |
| Rtw Investments, LP | 6.42M | $66.0M | 8.44% | -- | 2026-06-30 |
| BlackRock, Inc. | 4.97M | $51.0M | 6.53% | +1.86M | 2026-06-30 |
| State Street Corp | 3.55M | $36.0M | 4.66% | +2.73M | 2026-06-30 |
| Acorn Capital Advisors, LLC | 3.50M | $36.0M | 4.60% | -- | 2026-06-30 |
| Portolan Capital Management, LLC | 3.49M | $35.0M | 4.59% | +596.1K | 2026-06-30 |
| Saturn V Capital Management LP | 3.30M | $34.0M | 4.34% | +407.1K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.69M | $27.0M | 3.54% | +231.3K | 2026-06-30 |
| Geode Capital Management, LLC | 1.57M | $16.0M | 2.06% | +535.6K | 2026-06-30 |
| Millennium Management LLC | 1.09M | $11.0M | 1.44% | +33.8K | 2026-06-30 |